Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benralizumab Phase 2a in COPD with Sputum Eosinophilia
NCT01227278Phase 2Completed
- Sponsor
- MedImmune
- Start
- Nov 2010
- Primary completion
- Jan 2013
- Modality
- Monoclonal Antibodies
- Countries
- 7
01
Overview
A Phase 2 trial of benralizumab in chronic obstructive pulmonary disease (COPD), sponsored by MedImmune. Started Nov 2010; status: completed.
02
Drugs
benralizumab
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01227278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01227278.